Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States
PaperCitations, authors & open-access status
Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 20 citations, 2012 year and bronze oa status.
20
Citations
2012
Year
bronze
OA Status